Aug. 15 Company Quick Takes: IQVia's patient portal; plus Gilead/Galapagos and GeneCentric/Select ImmunoGenomics

IQVia launches patient portal
IQVia Holdings Inc. (NYSE:IQV) launched a cloud-based patient portal designed to reduce clinical trial costs

Read the full 187 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE